COVID-19 cases are on the rise again in Malaysia. As of May 2025, the Ministry of Health Malaysia (MOH) reports an increase in active infections, raising concerns over public health safety and the need for effective support options. One promising solution gaining attention is Androprotec, a natural supplement powered by andrographolide, clinically studied for its role in reducing the severity of COVID-19 symptoms.
According to the MOH’s KKMNOW Dashboard, Malaysia recorded over 8,800 active COVID-19 cases in early May 2025. While hospitalization remains under control, the uptick signals potential risks, especially for those with comorbidities or weakened immune systems.
Source: MOH COVID-19 Data Dashboard
Androprotec is a standardized herbal supplement containing 60 mg of andrographolide per tablet. Andrographolide is the active compound in Andrographis paniculata, a well-known medicinal plant used traditionally for fever, sore throat, and respiratory infections. Unlike many generic supplements, Androprotec is clinically aligned, with dosage recommendations based on human trials.
Clinical Study: Andrographolide vs. COVID-19
A randomized controlled trial published in 2021 evaluated the efficacy of andrographolide (50 mg, 3 times daily for 5 days) in mild COVID-19 patients. Key findings include:
- ✅ 0% pneumonia progression in treatment group vs. 10.7% in placebo group
- ✅ Trend toward faster viral clearance
- ✅ Well tolerated with no major side effects
Androprotec Dosage Recommendation
|
Condition |
Dosage |
Duration |
Benefits |
|
Mild to Moderate COVID-19 |
1 tablet, 2–3x daily |
5–10 days |
Supports recovery, reduces symptoms, prevents severity |
Final Thoughts
With COVID-19 resurging in Malaysia, taking proactive steps to protect your health is more important than ever. Androprotec offers a natural, science-backed option for immune support and respiratory health.
⚠️ This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before use.